Capital Medical University Reports Findings in Hepatitis B Virus (Machine learni ng-based model for predicting tumor recurrence after interventional therapy in H BV-related hepatocellular carcinoma patients with low preoperative ...)
Capital Medical University Reports Findings in Hepatitis B Virus (Machine learni ng-based model for predicting tumor recurrence after interventional therapy in H BV-related hepatocellular carcinoma patients with low preoperative ...)
By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News-New research on Liver Diseases and Con ditions - Hepatitis B Virus is the subject of a report. According to news report ing from Beijing, People's Republic of China, by NewsRx journalists, research st ated, "This study aimed to develop a prognostic nomogram for predicting the recu rrencefree survival (RFS) of hepatitis B virus (HBV)-related hepatocellular car cinoma (HCC) patients with low preoperative platelet-albumin-bilirubin (PALBI) s cores after transarterial chemoembolization (TACE) combined with local ablation treatment. We gathered clinical data from 632 HBV-related HCC patients who recei ved the combination treatment at Beijing You'an Hospital, affiliated with Capita l Medical University, from January 2014 to January 2020." Financial support for this research came from Bethune Charitable Foundation.
Key words
Beijing/People's Republic of China/Asi a/Bile Pigments/Bilirubin/Biological Factors/Cancer/Carcinomas/Cyborgs/DN A Viruses/Digestive System Diseases and Conditions/Emerging Technologies/Heal th and Medicine/Hepadnaviridae/Hepadnaviridae Infections/Hepatitis B Virus/L iver Cancer/Liver Diseases and Conditions/Machine Learning/Oncology/Orthohep adnavirus/Risk and Prevention/Therapy/Viral
NETL
NSTL